Association Between Systemic Comorbidity Burden and Glaucoma Progression: A 5-Year Cohort Study
Listen to this summary
The authors aimed to determine whether a higher systemic comorbidity burden, as measured by the age-adjusted Charlson Comorbidity Index (age-CCI), is linked to increased odds of glaucoma progression over a five-year period. Their findings indicate that each one-point increase in age-CCI correlates with a significant rise in the likelihood of progressing from early to moderate and severe stages of glaucoma, suggesting that incorporating systemic health assessments could enhance glaucoma risk stratification and management.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Journal of glaucoma
View all →More in Ophthalmology
View all →Jun 24, 2026 · The New England journal of medicine
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
Jun 24, 2026 · American journal of ophthalmology
The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · The New England journal of medicine
Prevention and Treatment of Peanut Allergy
Jun 24, 2026 · American journal of ophthalmology
Corneal Epithelial Alterations Associated With CDK4/6 Inhibitor Therapy in Hormone Receptor-Positive Breast Cancer
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


